195 related articles for article (PubMed ID: 25069848)
1. [Histological grading of epithelial ovarian cancer. Review and recommendation].
Hauptmann S; du Bois A; Meinhold-Herlein I; Pfisterer J; Avril S
Pathologe; 2014 Sep; 35(5):497-503. PubMed ID: 25069848
[TBL] [Abstract][Full Text] [Related]
2. Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.
Fujiwara K; McAlpine JN; Lheureux S; Matsumura N; Oza AM
Am Soc Clin Oncol Educ Book; 2016; 35():e247-57. PubMed ID: 27249730
[TBL] [Abstract][Full Text] [Related]
3. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
Ramalingam P
Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
[TBL] [Abstract][Full Text] [Related]
4. Low-grade serous carcinoma: molecular features and contemporary treatment strategies.
Angarita AM; Cholakian D; Fader AN
Expert Rev Anticancer Ther; 2015; 15(8):893-9. PubMed ID: 26040191
[TBL] [Abstract][Full Text] [Related]
5. [A new classification of ovarian tumors].
Frank GA; Moskvina LV; Andreeva YY
Arkh Patol; 2015; 77(4):40-50. PubMed ID: 26485779
[TBL] [Abstract][Full Text] [Related]
6. Grading ovarian serous carcinoma using a two-tier system.
Malpica A; Deavers MT; Lu K; Bodurka DC; Atkinson EN; Gershenson DM; Silva EG
Am J Surg Pathol; 2004 Apr; 28(4):496-504. PubMed ID: 15087669
[TBL] [Abstract][Full Text] [Related]
7. Low-grade serous ovarian cancer: A review.
Kaldawy A; Segev Y; Lavie O; Auslender R; Sopik V; Narod SA
Gynecol Oncol; 2016 Nov; 143(2):433-438. PubMed ID: 27581327
[TBL] [Abstract][Full Text] [Related]
8. The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
Ataseven B; Harter P; Grimm C; Heitz F; Heikaus S; Traut A; Kahl A; Kurzeder C; Prader S; du Bois A
Gynecol Oncol; 2016 Aug; 142(2):243-7. PubMed ID: 27208538
[TBL] [Abstract][Full Text] [Related]
9. Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all.
Groen RS; Gershenson DM; Fader AN
Gynecol Oncol; 2015 Feb; 136(2):373-83. PubMed ID: 25481800
[TBL] [Abstract][Full Text] [Related]
10. [Tumor size and prognosis for patients with epithelial ovarian carcinoma at early stage].
Lazarov N; Lazarov L; Lazarov S
Akush Ginekol (Sofiia); 2013; 52(4):10-2. PubMed ID: 24283071
[TBL] [Abstract][Full Text] [Related]
11. [The molecular biology of epithelial ovarian cancer].
Leary A; Pautier P; Tazi Y; Morice P; Duvillard P; Gouy S; Uzan C; Gauthier H; Balleyguier C; Lhommé C
Bull Cancer; 2012 Dec; 99(12):1161-73. PubMed ID: 23238064
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
13. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
14. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
15. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
[TBL] [Abstract][Full Text] [Related]
16. Ovarian serous carcinogenesis from tubal secretory cells.
Zhang W; Wei L; Li L; Yang B; Kong B; Yao G; Zheng W
Histol Histopathol; 2015 Nov; 30(11):1295-302. PubMed ID: 26174492
[TBL] [Abstract][Full Text] [Related]
17. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
[TBL] [Abstract][Full Text] [Related]
18. Low-grade epithelial ovarian cancer: what a radiologist should know.
Elsherif S; Javadi S; Viswanathan C; Faria S; Bhosale P
Br J Radiol; 2019 Mar; 92(1095):20180571. PubMed ID: 30604635
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies in epithelial ovarian cancer.
Kim A; Ueda Y; Naka T; Enomoto T
J Exp Clin Cancer Res; 2012 Feb; 31(1):14. PubMed ID: 22330607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
